OUR RESEARCH FOCUS

Currently, the only major treatment for heart failure is transplantation. However, it is estimated that less than 30% of patients survive to receive their new hearts. The local cell death following myocardial infarction plays a major role in the progression of cardiac dysfunction. Our laboratory focuses on various aspects of cardiac regeneration and preservation using molecular-based and biomaterials-based approaches to restoring function after cardiac injury.